CincyTech Strengthens Board with Financial Expert Eric Baumgardner

CincyTech LLC, a private equity firm focused on early-stage investments, has announced the election of Eric Baumgardner to its board and the hiring of Logan Hille as a Life Sciences Analyst. These strategic additions are aimed at enhancing the firm's capacity to invest in and develop innovative technologies, especially in life sciences. Eric Baumgardner brings a wealth of experience from his roles in corporate finance and strategic investments, notably as Vice President of Corporate Development at Western & Southern Financial Group and formerly at Procter & Gamble. Logan Hille, with a Ph.D. in Biological and Biomedical Sciences from Harvard University, adds robust scientific expertise, particularly in gene-editing technology. CincyTech CEO Emma Off emphasized that the new appointments underscore the firm's mission to be a leading capital partner in developing therapies and technologies that can significantly impact global health. The firm remains committed to supporting founders and research institutions in commercializing groundbreaking therapies and accelerating their entry into the marketplace.